{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:41:28Z","timestamp":1790710888487,"version":"4.1.0"},"reference-count":126,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T00:00:00Z","timestamp":1652659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003093","name":"Ministry of Higher Education, Malaysia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003093","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Glaucoma is an irreversible sight-threatening disorder primarily due to elevated intraocular pressure (IOP), leading to retinal ganglion cell (RGC) death by apoptosis with subsequent loss of optic nerve fibers. A considerable amount of empirical evidence has shown the significant association between tumor necrosis factor cytokine (TNF; TNF\u03b1) and glaucoma; however, the exact role of TNF in glaucoma progression remains unclear. Total inhibition of TNF against its receptors can cause side effects, although this is not the case when using selective inhibitors. In addition, TNF exerts its antithetic roles\n                    <jats:italic>via<\/jats:italic>\n                    stimulation of two receptors, TNF receptor I (TNFR1) and TNF receptor II (TNFR2). The pro-inflammatory responses and proapoptotic signaling pathways predominantly mediated through TNFR1, while neuroprotective and anti-apoptotic signals induced by TNFR2. In this review, we attempt to discuss the involvement of TNF receptors (TNFRs) and their signaling pathway in ocular tissues with focus on RGC and glial cells in glaucoma. This review also outlines the potential application TNFRs agonist and\/or antagonists as neuroprotective strategy from a therapeutic standpoint. Taken together, a better understanding of the function of TNFRs may lead to the development of a treatment for glaucoma.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.857812","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T05:21:20Z","timestamp":1652678480000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["Targeting Differential Roles of Tumor Necrosis Factor Receptors as a Therapeutic Strategy for Glaucoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Lidawani","family":"Lambuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhana","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Zulfiqah","family":"Sadikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nor Asyikin","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramlah","family":"Kadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurul Alimah Abdul","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Plebanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohimah","family":"Mohamud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11686","article-title":"Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future","volume":"12","author":"Allison","year":"2020","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.3390\/cells10061372","article-title":"Multifactorial Pathogenic Processes of Retinal Ganglion Cell Degeneration in Glaucoma Towards Multi-Target Strategies for Broader Treatment Effects","volume":"10","author":"Tezel","year":"2021","journal-title":"Cells"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.2147\/DDDT.S80594","article-title":"Neuroprotective Therapies for Glaucoma","volume":"9","author":"Song","year":"2015","journal-title":"Drug Des Devel Ther"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2016.12.005","article-title":"Neuroprotection for Glaucoma: Requirements for Clinical Translation","volume":"157","author":"Levin","year":"2017","journal-title":"Exp Eye Res"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.1007\/978-981-13-2137-5_23","article-title":"The Molecular Basis of Retinal Ganglion Cell Death in Glaucoma","volume-title":"Intraocular and Intracranial Pressure Gradient in Glaucoma","author":"Zhang","year":"2019"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00065","article-title":"Adaptive Immunity: New Aspects of Pathogenesis Underlying Neurodegeneration in Glaucoma and Optic Neuropathy","volume":"11","author":"Jiang","year":"2020","journal-title":"Front Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4103\/1673-5374.130093","article-title":"Mechanisms of Secondary Degeneration After Partial Optic Nerve Transection","volume":"9","author":"Li","year":"2014","journal-title":"Neural Regener Res"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6257(99)00029-6","article-title":"Apoptosis of Retinal Ganglion Cells in Glaucoma: An Update of the Molecular Pathways Involved in Cell Death","volume":"43","author":"Nickells","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/14737175.2019.1618710","article-title":"Neurodegenerative Disease Treatments by Direct TNF Reduction, SB623 Cells, Maraviroc and Irisin and MCC950, From an Inflammatory Perspective \u2013 A Commentary","volume":"19","author":"Clark","year":"2019","journal-title":"Expert Rev Neurother"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2017.02.014","article-title":"Neuroinflammation in Glaucoma: A New Opportunity","volume":"157","author":"Williams","year":"2017","journal-title":"Exp Eye Res"},{"key":"B11","doi-asserted-by":"crossref","DOI":"10.1016\/S0079-6123(08)01128-X","article-title":"TNF-Alpha Signaling in Glaucomatous Neurodegeneration","volume":"173","author":"Tezel","year":"2008","journal-title":"Prog Brain Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/nri1184","article-title":"Signalling Pathways of the TNF Superfamily: A Double-Edged Sword","volume":"3","author":"Aggarwal","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"B13","first-page":"1","article-title":"Tumour Necrosis Factor Alpha: A Major Cytokine of Brain Neuroinflammation","volume-title":"Cytokines, ed Payam Benzadi","author":"Muhammad","year":"2019"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","article-title":"TNF and its Receptors in the CNS: The Essential, the Desirable and the Deleterious Effects","volume":"302","author":"Probert","year":"2015","journal-title":"Neuroscience"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.22-07-j0001.2002","article-title":"Neurodegenerative and Neuroprotective Effects of Tumor Necrosis Factor (TNF) in Retinal Ischemia: Opposite Roles of TNF Receptor 1 and TNF Receptor 2","volume":"22","author":"Fontaine","year":"2002","journal-title":"J Neurosci"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202659","article-title":"TNFR2 is Critical for the Stabilization of the CD4+ Foxp3+ Regulatory T Cell Phenotype in the Inflammatory Environment","volume":"190","author":"Chen","year":"2013","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02572","article-title":"The Key Role of TNF-TNFR2 Interactions in the Modulation of Allergic Inflammation: A Review","volume":"9","author":"Ahmad","year":"2018","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6313242","DOI":"10.1155\/2019\/6313242","article-title":"A Perspective Review on the Role of Nanomedicine in the Modulation of TNF-TNFR2 Axis in Breast Cancer Immunotherapy","volume":"2019","author":"Al-Hatamleh","year":"2019","journal-title":"J Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.preteyeres.2018.12.002","article-title":"Immune Cells in the Retina and Choroid: Two Different Tissue Environments That Require Different Defenses and Surveillance","volume":"70","author":"McMenamin","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.visres.2017.05.009","article-title":"The Inner Blood-Retinal Barrier: Cellular Basis and Development","volume":"139","author":"D\u00edaz-Cor\u00e1nguez","year":"2017","journal-title":"Vision Res"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-91584-7","article-title":"Comparative Transcriptome Analysis of Inner Blood-Retinal Barrier and Blood\u2013Brain Barrier in Rats","volume":"11","author":"Li","year":"2021","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1469-7580.2002.00064.x","article-title":"Astrocyte-Endothelial Interactions and Blood-Brain Barrier Permeability","volume":"200","author":"Abbott","year":"2002","journal-title":"J Anat"},{"key":"B23","doi-asserted-by":"publisher","first-page":"11877","DOI":"10.3390\/ijms222111877","article-title":"Wnt Signaling in Inner Blood\u2013Retinal Barrier Maintenance","volume":"22","author":"Yemanyi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000001015","article-title":"Blood-Retinal Barrier as a Converging Pivot in Understanding the Initiation and Development of Retinal Diseases","volume":"133","author":"Yang","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1102574","article-title":"Ocular Immune Privilege: The Eye Takes a Dim But Practical View of Immunity and Inflammation","volume":"74","author":"Streilein","year":"2003","journal-title":"J Leukoc Biol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S1350-9462(98)00022-6","article-title":"Immunoregulatory Mechanisms of the Eye","volume":"18","author":"Streilein","year":"1999","journal-title":"Prog Retin Eye Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/ni1328","article-title":"See No Evil, Hear No Evil, do No Evil: The Lessons of Immune Privilege","volume":"7","author":"Niederkorn","year":"2006","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"100998","DOI":"10.1016\/j.preteyeres.2021.100998","article-title":"Molecular Regulation of Neuroinflammation in Glaucoma: Current Knowledge and the Ongoing Search for New Treatment Targets","volume":"87","author":"Tezel","year":"2021","journal-title":"Prog Retin Eye Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"100916","DOI":"10.1016\/j.preteyeres.2020.100916","article-title":"Inflammation in Glaucoma: From the Back to the Front of the Eye, and Beyond","volume":"83","author":"Baudouin","year":"2020","journal-title":"Prog Retin Eye Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0860","article-title":"Expression of Acute-Phase Response Proteins in Retinal Muller Cells in Diabetes","volume":"46","author":"Gerhardinger","year":"2005","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-11175","article-title":"Innate Immune Network in the Retina Activated by Optic Nerve Crush","volume":"54","author":"Templeton","year":"2013","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/1-4020-2541-6_16","article-title":"Role of M\u00fcller Glia in Neuroprotection and Regeneration in the Retina","author":"Garcia","year":"2003","journal-title":"Histol Histopathol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.preteyeres.2015.06.003","article-title":"Glia\u2013neuron Interactions in the Mammalian Retina","volume":"51","author":"Vecino","year":"2016","journal-title":"Prog Retin Eye Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1089\/neu.1997.14.665","article-title":"NMDA-Receptor Antagonist Protects Neurons From Secondary Degeneration After Partial Optic Nerve Crush","volume":"14","author":"Yoles","year":"1997","journal-title":"J Neurotrauma"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2003.10.029","article-title":"Role of Tumor Necrosis Factor Receptor-1 in the Death of Retinal Ganglion Cells Following Optic Nerve Crush Injury in Mice","volume":"996","author":"Tezel","year":"2004","journal-title":"Brain Res"},{"key":"B36","article-title":"Optic Nerve Transection in Monkeys may Result in Secondary Degeneration of Retinal Ganglion Cells","volume":"42","author":"Levkovitch\u2013Verbin","year":"2001","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2009.02.005","article-title":"Immunoregulation of Retinal Ganglion Cell Fate in Glaucoma","volume":"88","author":"Wax","year":"2009","journal-title":"Exp Eye Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2010.08.009","article-title":"Neuroprotection in Glaucoma\u2013is There a Future Role","volume":"91","author":"Baltmr","year":"2010","journal-title":"Exp Eye Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200404000-00003","article-title":"The Immune System and Glaucoma","volume":"15","author":"Tezel","year":"2004","journal-title":"Curr Opin Ophthalmol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-014-0194-3","article-title":"Tumor Necrosis Factor Alpha has an Early Protective Effect on Retinal Ganglion Cells After Optic Nerve Crush","volume":"11","author":"Mac Nair","year":"2014","journal-title":"J Neuroinflamm"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3129\/i07-050","article-title":"Modulating the Immune System: A Vaccine for Glaucoma","volume":"42","author":"Schwartz","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.02-0646","article-title":"A Model to Study Differences Between Primary and Secondary Degeneration of Retinal Ganglion Cells in Rats by Partial Optic Nerve Transection","volume":"44","author":"Levkovitch-Verbin","year":"2003","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.arr.2016.05.012","article-title":"From DNA Damage to Functional Changes of the Trabecular Meshwork in Aging and Glaucoma","volume":"29","author":"Sacc\u00e0","year":"2016","journal-title":"Ageing Res Rev"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2010.09.005","article-title":"A Biomechanical Paradigm for Axonal Insult Within the Optic Nerve Head in Aging and Glaucoma","volume":"93","author":"Burgoyne","year":"2011","journal-title":"Exp Eye Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2017.00451","article-title":"Axonal Degeneration During Aging and its Functional Role in Neurodegenerative Disorders","volume":"11","author":"Salvadores","year":"2017","journal-title":"Front Neurosci"},{"key":"B46","first-page":"36","article-title":"TNF-\u03b1, TNF Receptors and Their Complex Implications in Therapy","volume":"4","author":"Churchill","year":"2020","journal-title":"Asian J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00091","article-title":"TNFR1 and TNFR2 in the Control of the Life and Death Balance of Macrophages","volume":"7","author":"Wajant","year":"2019","journal-title":"Front Cell Dev Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00784","article-title":"Role of TNF\u2013TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications","volume":"9","author":"Yang","year":"2018","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.20-23-08693.2000","article-title":"Increased Production of Tumor Necrosis Factor-\u03b1 by Glial Cells Exposed to Simulated Ischemia or Elevated Hydrostatic Pressure Induces Apoptosis in Cocultured Retinal Ganglion Cells","volume":"20","author":"Tezel","year":"2000","journal-title":"J Neurosci"},{"key":"B50","first-page":"9","article-title":"Localization of Tumor Necrosis Factor Receptor Messenger RNA in Normal and Herpes Simplex Virus-Infected Mouse Eyes","volume":"38","author":"Cunningham","year":"1997","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.740057","article-title":"TNF-\u03b1 in Uveitis: From Bench to Clinic","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245143","article-title":"Effects of TNF\u03b1 Receptor TNF-Rp55-Or TNF-Rp75-Deficiency on Corneal Neovascularization and Lymphangiogenesis in the Mouse","volume":"16","author":"Maier","year":"2021","journal-title":"PloS One"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1996.0120","article-title":"Soluble Tumor Necrosis Factor Receptors are Present in Human Vitreous and Shed by Retinal Pigment Epithelial Cells","volume":"63","author":"Sippy","year":"1996","journal-title":"Exp Eye Res"},{"key":"B54","article-title":"TNF-\u03b1 and TNF-\u03b1 Receptor-1 in the Retina of Normal and Glaucomatous Eyes","volume":"42","author":"Tezel","year":"2001","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.5.666","article-title":"Matrix Metalloproteinases and Tumor Necrosis Factor \u03b1 in Glaucomatous Optic Nerve Head","volume":"118","author":"Yan","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr199","article-title":"Inhibition of Soluble Tumour Necrosis Factor Is Therapeutic in Experimental Autoimmune Encephalomyelitis and Promotes Axon Preservation and Remyelination","volume":"134","author":"Brambilla","year":"2011","journal-title":"Brain"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1002\/art.38755","article-title":"Selective Tumor Necrosis Factor Receptor I Blockade Is Antiinflammatory and Reveals Immunoregulatory Role of Tumor Necrosis Factor Receptor II in Collagen-Induced Arthritis","volume":"66","author":"McCann","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-31957-7","article-title":"Anti-TNFR1 Targeting in Humanized Mice Ameliorates Disease in a Model of Multiple Sclerosis","volume":"8","author":"Williams","year":"2018","journal-title":"Sci Rep"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-13984-y","article-title":"TNFR1 Inhibition With a Nanobody Protects Against EAE Development in Mice","volume":"7","author":"Steeland","year":"2017","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1074\/jbc.M707933200","article-title":"Creation and X-Ray Structure Analysis of the Tumor Necrosis Factor Receptor-1-Selective Mutant of a Tumor Necrosis Factor-\u03b1 Antagonist","volume":"283","author":"Shibata","year":"2008","journal-title":"J Biol Chem"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1006\/exnr.1998.6797","article-title":"Hyperalgesia in Experimental Neuropathy is Dependent on the TNF Receptor 1","volume":"151","author":"Sommer","year":"1998","journal-title":"Exp Neurol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2004.03.011","article-title":"Ligands Working as Receptors: Reverse Signaling by Members of the TNF Superfamily Enhance the Plasticity of the Immune System","volume":"15","author":"Eissner","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.3390\/ijms23042229","article-title":"Splenic Architecture and Function Requires Tight Control of Transmembrane TNF Expression","volume":"23","author":"Jeucken","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2013.89","article-title":"Protective Role of Tumor Necrosis Factor (TNF) Receptors in Chronic Intestinal Inflammation: TNFR1 Ablation Boosts Systemic Inflammatory Response","volume":"93","author":"Wang","year":"2013","journal-title":"Lab Invest"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2019.00049","article-title":"Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer\u2019s Disease","volume":"13","author":"Ort\u00ed-Casa\u00f1","year":"2019","journal-title":"Front Neurosci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027621","article-title":"TNF Receptor 2 Selective Agonist Rescues Human Neurons From Oxidative Stress-Induced Cell Death","volume":"6","author":"Fischer","year":"2011","journal-title":"PloS One"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S162999","article-title":"Association of Increased Levels of Plasma Tumor Necrosis Factor Alpha With Primary Open-Angle Glaucoma","volume":"12","author":"Kondkar","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200523348","article-title":"Renal Cell\u2013Expressed TNF Receptor 2, Not Receptor 1, is Essential for the Development of Glomerulonephritis","volume":"115","author":"Vielhauer","year":"2005","journal-title":"J Clin Investig"},{"key":"B69","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3","article-title":"Tumor Necrosis Factor-\u03b1: A Potentially Neurodestructive Cytokine Produced by Glia in the Human Glaucomatous Optic Nerve Head","volume":"32","author":"Yuan","year":"2000","journal-title":"Glia"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-4247","article-title":"Tumor Necrosis Factor-\u03b1 Concentrations in the Aqueous Humor of Patients With Glaucoma","volume":"51","author":"Sawada","year":"2010","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S19453","article-title":"Tumor Necrosis Factor-Alpha (TNF-\u03b1) Levels in Aqueous Humor of Primary Open Angle Glaucoma","volume":"5","author":"Balaiya","year":"2011","journal-title":"Clin Ophthalmol (Auckland NZ)"},{"key":"B72","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/genes13010054","article-title":"Evaluating TNF-\u03b1 and Interleukin-2 (IL-2) Levels in African American Primary Open-Angle Glaucoma Patients","volume":"13","author":"Alapati","year":"2022","journal-title":"Genes"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S155168","article-title":"Elevated Levels of Plasma Tumor Necrosis Factor Alpha in Patients With Pseudoexfoliation Glaucoma","volume":"12","author":"Kondkar","year":"2018","journal-title":"Clin Ophthalmol (Auckland NZ)"},{"key":"B74","doi-asserted-by":"publisher","first-page":"621146","DOI":"10.3389\/fphar.2021.621146","article-title":"Metabolomic Profiling of Aqueous Humor and Plasma in Primary Open Angle Glaucoma Patients Points Towards Novel Diagnostic and Therapeutic Strategy","author":"Tang","year":"2021","journal-title":"Front Pharmacol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"4359","DOI":"10.1167\/iovs.03-1403","article-title":"Variants in Optineurin Gene and Their Association With Tumor Necrosis Factor-\u03b1 Polymorphisms in Japanese Patients With Glaucoma","volume":"45","author":"Funayama","year":"2004","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B76","article-title":"Polymorphism in the TNF-\u03b1(-863) Locus Associated With Reduced Risk of Primary Open Angle Glaucoma","volume":"18","author":"Wang","year":"2012","journal-title":"Mol Vis"},{"key":"B77","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.gene.2019.05.035","article-title":"Association of TNF-\u03b1 Gene Alterations (C.-238G>A, C.-308G>A, C.-857C>T, C.-863C>A) With Primary Glaucoma in North Indian Cohort","volume":"709","author":"Passan","year":"2019","journal-title":"Gene"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF With TNF Receptor Type 2 Promotes Expansion and Function of Mouse CD4+CD25+ T Regulatory Cells","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2016.1205629","article-title":"Elevated Regulatory T Cell Levels in Glaucoma Patients in Comparison to Healthy Controls","volume":"42","author":"Bell","year":"2016","journal-title":"Curr Eye Res"},{"key":"B80","article-title":"The Increased Level Of Circulating And Functioning Treg Lymphocytes Correlates With Visual Field Rate Of Progression In Primary Open Angle Glaucoma","volume-title":"Inves Opthalmol.","author":"Gandolfi","year":"2011"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.8.5800","article-title":"Akt\/Protein Kinase B Inhibits Cell Death by Preventing the Release of Cytochrome C From Mitochondria","volume":"19","author":"Kennedy","year":"1999","journal-title":"Mol Cell Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M311766200","article-title":"Tumor Necrosis Factor (TNF)-Mediated Neuroprotection Against Glutamate-Induced Excitotoxicity Is Enhanced by N-Methyl-D-Aspartate Receptor Activation: Essential Role of a TNF Receptor 2-Mediated Phosphatidylinositol 3-Kinase-Dependent NF-\u03baB Pathway","volume":"279","author":"Marchetti","year":"2004","journal-title":"J Biol Chem"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1126\/science.7544915","article-title":"TRAF2-Mediated Activation of NF-Kappa B by TNF Receptor 2 and CD40","volume":"269","author":"Rothe","year":"1995","journal-title":"Sci"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2005.01.022","article-title":"Comparative Gene Array Analysis of TNF-\u03b1-Induced MAPK and NF\u2013\u03bab Signaling Pathways Between Retinal Ganglion Cells and Glial Cells","volume":"81","author":"Tezel","year":"2005","journal-title":"Exp Eye Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.8.2680-2698.2003","article-title":"From Calcium to NF-\u03bab Signaling Pathways in Neurons","volume":"23","author":"Lilienbaum","year":"2003","journal-title":"Mol Cell Biol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcn.2010.06.014","article-title":"Activation of TNF Receptor 2 in Microglia Promotes Induction of Anti-Inflammatory Pathways","volume":"45","author":"Veroni","year":"2010","journal-title":"Mol Cell Neurosci"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2801-06.2006","article-title":"Tumor Necrosis Factor-\u03b1 Mediates Oligodendrocyte Death and Delayed Retinal Ganglion Cell Loss in a Mouse Model of Glaucoma","volume":"26","author":"Nakazawa","year":"2006","journal-title":"J Neurosci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.10-6509","article-title":"Tumor Necrosis Factor-\u03b1 Mediates Photoreceptor Death in a Rodent Model of Retinal Detachment","volume":"52","author":"Nakazawa","year":"2011","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2007.02.016","article-title":"Serious Adverse Events With Infliximab: Analysis of Spontaneously Reported Adverse Events","volume":"5","author":"Hansen","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11910-017-0742-1","article-title":"CNS Demyelination With TNF-\u03b1 Blockers","volume":"17","author":"Kemanetzoglou","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1093\/jnen\/nlv027","article-title":"Inflammatory Cytokines are Involved in Focal Demyelination in Leprosy Neuritis","volume":"75","author":"Andrade","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semarthrit.2005.01.002","article-title":"TNF Pathophysiology in Murine Models of Chronic Inflammation and Autoimmunity","volume":"34","author":"Kollias","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"B93","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The Role of Tumor Necrosis Factor Alpha (TNF-\u03b1) in Autoimmune Disease and Current TNF-\u03b1 Inhibitors in Therapeutics","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2018.0605","article-title":"Anti\u2013tumor Necrosis Factor Therapy and Incidence of Parkinson Disease Among Patients With Inflammatory Bowel Disease","volume":"75","author":"Peter","year":"2018","journal-title":"JAMA Neurol"},{"key":"B95","first-page":"S152","article-title":"Side Effects of Anti-TNF Therapy: Current Knowledge","volume":"20","author":"Antoni","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2010.10.053","article-title":"Anti-TNF-\u03b1 Reduces Amyloid Plaques and Tau Phosphorylation and Induces CD11c-Positive Dendritic-Like Cell in the APP\/PS1 Transgenic Mouse Brains","volume":"1368","author":"Shi","year":"2011","journal-title":"Brain Res"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbr.2016.06.001","article-title":"Infliximab Ameliorates AD-Associated Object Recognition Memory Impairment","volume":"311","author":"Kim","year":"2016","journal-title":"Behav Brain Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03445.x","article-title":"Cognitive Improvement With Intrathecal Administration of Infliximab in a Woman With Alzheimer's Disease","volume":"59","author":"Shi","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"B99","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1756-0500-2-28","article-title":"Rapid Intracerebroventricular Delivery of Cu-DOTA-Etanercept After Peripheral Administration Demonstrated by PET Imaging","volume":"2","author":"Tobinick","year":"2009","journal-title":"BMC Res Notes"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229819","article-title":"Tumor Necrosis Factor (TNF) Blocking Agents are Associated With Lower Risk for Alzheimer\u2019s Disease in Patients With Rheumatoid Arthritis and Psoriasis","volume":"15","author":"Zhou","year":"2020","journal-title":"PloS One"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2019.02.003","article-title":"Central Nervous System Involvement in Rheumatoid Arthritis Patients and the Potential Implications of Using Biological Agents","volume":"32","author":"Atzeni","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-020-01930-1","article-title":"Transgenic Inhibition of Astroglial NF-\u03bab Restrains the Neuroinflammatory and Neurodegenerative Outcomes of Experimental Mouse Glaucoma","volume":"17","author":"Yang","year":"2020","journal-title":"J Neuroinflamm"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s40135-019-00212-1","article-title":"Immunomodulation as a Neuroprotective Strategy for Glaucoma Treatment","volume":"7","author":"Bar\u0131\u015f","year":"2019","journal-title":"Curr Ophthalmol Rep"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0040065","article-title":"Etanercept, A Widely Used Inhibitor of Tumor Necrosis Factor-\u03b1 (TNF-\u03b1), Prevents Retinal Ganglion Cell Loss in a Rat Model of Glaucoma","volume":"7","author":"Roh","year":"2012","journal-title":"PloS One"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-9101","article-title":"An Astrocyte-Specific Proteomic Approach Toinflammatory Responses in Experimental Rat Glaucoma","volume":"53","author":"Tezel","year":"2012","journal-title":"Invest Opthalmol Vis Sci"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphs.2017.02.012","article-title":"Toll-Like Receptor 4 Inhibitor Protects Against Retinal Ganglion Cell Damage Induced by Optic Nerve Crush in Mice","volume":"133","author":"Nakano","year":"2017","journal-title":"J Pharmacol Sci"},{"key":"B107","unstructured":"JmaeffS\n          CanadaMcGill UniversityAnti-Neurotoxic and Pro-Survival in Degenerative Disease: The Relevance, Utility, and Challenges of Small Molecule Development2020"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms131113926","article-title":"The Proteomics Big Challenge for Biomarkers and New Drug-Targets Discovery","volume":"13","author":"Savino","year":"2012","journal-title":"Int J Mol Sci"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1080\/08830180212060","article-title":"Cytokines in Immunotherapy of Experimental Uveitis","volume":"21","author":"De Kozak","year":"2002","journal-title":"Int Rev Immunol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2126-1","article-title":"Evidence-Based, Interdisciplinary Guidelines for Anti-Inflammatory Treatment of Uveitis Associated With Juvenile Idiopathic Arthritis","volume":"32","author":"Heiligenhaus","year":"2012","journal-title":"Rheumatol Int"},{"key":"B111","doi-asserted-by":"publisher","first-page":"11206721211055965","DOI":"10.1177\/11206721211055965","article-title":"Cytokine Profile in Tear and Aqueous Humor of Primary Open-Angle Patients as a Prognostic Factor for Trabeculectomy Outcome","author":"Burgos-Blasco","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2147\/DDDT.S63320","article-title":"Topical Infliximab for the Suppression of Wound Healing Following Experimental Glaucoma Filtration Surgery","volume":"8","author":"Turgut","year":"2014","journal-title":"Drug Des Devel Ther"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.3387","article-title":"Potential Effect of Tumor Necrosis Factor Inhibitors on Trabeculectomy With Mitomycin C for Patients With Juvenile Idiopathic Arthritis\u2013Related Uveitic Glaucoma: A Retrospective Analysis","volume":"133","author":"Leinonen","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2012-302292","article-title":"Adalimumab Therapy for Refractory Uveitis: Results of a Multicentre, Open-Label, Prospective Trial","volume":"97","author":"Suhler","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1546-0096-11-16","article-title":"Superior Efficacy of Adalimumab in Treating Childhood Refractory Chronic Uveitis When Used as First Biologic Modifier Drug: Adalimumab as Starting Anti-TNF-\u03b1 Therapy in Childhood Chronic Uveitis","volume":"11","author":"Simonini","year":"2013","journal-title":"Pediatr Rheumatol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.02.018","article-title":"Treatment of Refractory Uveitis With Adalimumab: A Prospective Multicenter Study of 131 Patients","volume":"119","author":"D\u00edaz-Llopis","year":"2012","journal-title":"Ophthalmology"},{"key":"B117","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","article-title":"Expert Panel Recommendations for the Use of Anti\u2013Tumor Necrosis Factor Biologic Agents in Patients With Ocular Inflammatory Disorders","volume":"121","author":"Levy-Clarke","year":"2014","journal-title":"Ophthalmology"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000071","article-title":"Alkali Burn to the Eye","volume":"33","author":"Cade","year":"2014","journal-title":"Cornea"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000002106","article-title":"Glaucoma After Corneal Trauma or Surgery\u2014A Rapid, Inflammatory, IOP-Independent Pathway","volume":"38","author":"Dohlman","year":"2019","journal-title":"Cornea"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.53.3.457","article-title":"TNF Neutralization in MS: Results of a Randomized, Placebo-Controlled Multicenter Study","volume":"53","year":"1999","journal-title":"Neurology"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12348-020-00202-6","article-title":"A Review of Ocular Adverse Events of Biological Anti-TNF Drugs","volume":"10","author":"Susanna","year":"2020","journal-title":"J Ophthalmic Inflammn Infect"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2801-06.2006","article-title":"Tumor Necrosis Factor- Mediates Oligodendrocyte Death and Delayed Retinal Ganglion Cell Loss in a Mouse Model of Glaucoma","volume":"26","author":"Nakazawa","year":"2006","journal-title":"J Neurosci"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-06-02058.2001","article-title":"Reduction of Potassium Currents and Phosphatidylinositol 3-Kinase-Dependent Akt Phosphorylation by Tumor Necrosis Factor-\u03b1 Rescues Axotomized Retinal Ganglion Cells From Retrograde Cell Death In Vivo","volume":"21","author":"Diem","year":"2001","journal-title":"J Neurosci"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00401","article-title":"Selective Targeting of TNF Receptors as a Novel Therapeutic Approach","volume":"8","author":"Fischer","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1605195113","article-title":"Essential Protective Role of Tumor Necrosis Factor Receptor 2 in Neurodegeneration","volume":"113","author":"Dong","year":"2016","journal-title":"Proc Natl Acad Sci"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708300","article-title":"Counteracting the Effects of TNF Receptor-1 has Therapeutic Potential in Alzheimer's Disease","volume":"10","author":"Steeland","year":"2018","journal-title":"EMBO Mol Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.857812\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T05:21:32Z","timestamp":1652678492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.857812\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,16]]},"references-count":126,"alternative-id":["10.3389\/fimmu.2022.857812"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.857812","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,16]]},"article-number":"857812"}}